Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Reck, M; von Pawel, J; Macha, HN; Kaukel, E; Deppermann, KM; Bonnet, R; Ulm, K; Hessler, S; Gatzemeier, U 
Titel:
Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer. 
Abstract:
BACKGROUND: Paclitaxel administered in combination with a topoisomerase-II inhibitor (such as etoposide) and carboplatin is an effective and safe first-line treatment for patients with small-cell lung cancer (SCLC). We conducted a randomized phase III multicenter trial to determine whether paclitaxel plus etoposide plus carboplatin improves the outcome of patients with primary SCLC relative to standard chemotherapy (carboplatin, etoposide, and vincristine). METHODS: Between January 1998 and Dece...    »
 
Zeitschriftentitel:
J Natl Cancer Inst 
Jahr:
2003 
Band / Volume:
95 
Heft / Issue:
15 
Seitenangaben Beitrag:
1118-27 
Sprache:
eng 
Print-ISSN:
0027-8874 
TUM Einrichtung:
r Medizinische Statistik und Epidemiologie